Impact Factor
4.18
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.69
1,513 total citations
h5-index
54
h5 depth signal
Cited share
92.2%
249 of 270
Total citations
1,513
Citation footprint
Metric signal
5.30
External metric anchor
Self-citation
1.3%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
492
Italy
471
Egypt
218
Saudi Arabia
190
Turkey
120
Citing Fields of Research
Synthesis
468
Protein Structure & Folding
311
Cancer Drugs
292
Drug Delivery Systems
229
Cancer, Autophagy & Apoptosis
206
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,497
Articles tracked across the journal lifetime
Indexed publication set
270
249 cited publications
Last 12 months
130
10.8 publications/month
Open access share
100.0%
130 OA publications in the last year
Leading citing country
China
492 citing publications
Leading citing field
Synthesis
468 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v17n1, Feb. 2002-
v17n1, Feb. 2002-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer, Autophagy & Apoptosis
Cancer Drugs
Synthesis
Immunology
Phytochemicals
Neurodegenerative Disorders
Oncology
Broad Categories
Biochemistry
Chemistry
Cancer, Autophagy & Apoptosis
Protein Structure & Folding
Cancer Drugs
Phytochemicals
Molecular & Cellular Toxicology
Virology
MeSH Descriptors
Biochemistry
Enzyme Inhibitors
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/14756366.2026.2743434
Open DOI
Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells
02
DOI 10.1080/14756366.2026.2742455
Open DOI
Structure-activity relationship of Cu(II) and Pd(II) thiosemicarbazone complexes with anticancer and antibacterial properties
03
DOI 10.1080/14756366.2026.2747402
Open DOI
Rational structure-guided identification of a Bcl-2-targeting peptide with antiproliferative effects on colorectal cancer cells
Bcl-2 is critical for tumour survival and serves as a promising anticancer drug target. Herein, a series of novel Bcl-2-targeted peptides were identified through structure-based virtual screening and systematic biological validation. Fou...
04
DOI 10.1080/14756366.2026.2744392
Open DOI
Research progress on ATP-citrate lyase and its inhibitors: a metabolic-epigenetic perspective
05
DOI 10.1080/14756366.2026.2713724
Open DOI
Structure-guided discovery of novel ERα-binding peptides with in vitro antiproliferative activity
06
DOI 10.1080/14756366.2026.2681363
Open DOI
Identification of benzoxazine scaffold derivatives as novel CDK4 inhibitors for the treatment of cancer
07
DOI 10.1080/14756366.2026.2724128
Open DOI
Integrated computational and experimental identification of a novel ML-IAP-targeting peptide with antiproliferative activity in leukaemia cells
Leukaemia is a haematological malignancy characterised by the transformation of haematopoietic progenitor cells and diffuse infiltration of the bone marrow1. In recent years, the global numbers of ...
08
DOI 10.1080/14756366.2026.2732821
Open DOI
Molecular insights into triazole-based compounds for triple-negative breast cancer treatment
Triple negative breast cancer (TNBC) is a distinct and aggressive type of breast cancer in which there is no expression of oestrogen receptors (ER), progesterone receptors (PR), or human epidermal ...
09
DOI 10.1080/14756366.2026.2736806
Open DOI
Identification of Crocin I as a positive modulator of GSTP1 with potential relevance to prostate cancer
10
DOI 10.1080/14756366.2026.2730846
Open DOI
Structure-based rational design and biological evaluation of a quinazoline-based EGFR exon 20 insertion inhibitor
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and remains one of the most prevalent and deadly malignancies worldwide.1 Epidermal growth factor receptor...
Bibliographical & Catalog Notes
Place of publication varies.
Print issues ceased with v. 27, no. 6 (2012).
Also issued online.